P-139 - A NOVEL DOUBLE-TRACER TECHNIQUE TO CHARACTERIZE ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION OF ORAL [14C]MITAPIVAT AND CONCOMITANT INTRAVENOUS MICRODOSE ADMINISTRATION OF [13C6]MITAPIVAT IN HUMANS.
C. Prakash1, V. Iyer1, H. Mangus1, E. Simone1, H. Yang2, Y. Yan1; 1Agios Pharmaceuticals, Inc., Cambridge, MA, USA, 2Disc Medicine, Cambridge, MA, USA.